Literature DB >> 9305887

A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.

S Hinderlich1, R Stäsche, R Zeitler, W Reutter.   

Abstract

Biosynthesis of N-acetylneuraminic acid (Neu5Ac), a prominent component of glycoconjugates, is initiated by the action of UDP-N-acetylglucosamine 2-epimerase (UDP-GlcNAc 2-epimerase, EC 5.1. 3.14) and N-acetylmannosamine kinase (ManNAc kinase, EC 2.7.1.60). We demonstrate for the first time that the two activities are parts of one bifunctional enzyme in rat liver. The enzyme was purified to homogeneity from rat liver cytosol using salmine sulfate precipitation and chromatography on phenyl-Sepharose, ATP-agarose, and Mono Q. The purification resulted in one polypeptide with an apparent molecular mass of 75 kDa. Immunoprecipitation with a polyclonal antibody against the polypeptide reduced both enzyme activities in equal amounts. Gel filtration analysis of purified UDP-GlcNAc 2-epimerase/ManNAc kinase showed that the polypeptide self-associates as a dimer and as a hexamer with apparent molecular masses of 150 and 450 kDa, respectively. The hexamer was fully active for both enzyme activities, whereas the dimer catalyzed only the phosphorylation of N-acetylmannosamine (ManNAc). Incubation of the dimer with UDP-N-acetylglucosamine led to reassembly of the fully active hexamer; maximal quantities of the hexamer were produced after incubation for 3 h. Kinetic analysis of purified hexameric and dimeric enzyme revealed significantly lower Michaelis constants (93 +/- 3 to 121 +/- 15 microM for ManNAc and 1.18 +/- 0. 13 to 1.67 +/- 0.20 mM for ATP) and higher cooperativity (Hill coefficients of 1.42 +/- 0.16 to 1.17 +/- 0.06 for ManNAc and 1.30 +/- 0.09 to 1.05 +/- 0.14 for ATP) for the hexamer for both substrates of ManNAc kinase. The Michaelis constant of UDP-GlcNAc 2-epimerase for its substrate was 11 +/- 2 microM. The Hill coefficient of 0.45 +/- 0.07 represents strongly negative cooperativity in substrate binding. UDP-GlcNAc 2-epimerase was feedback inhibited by CMP-Neu5Ac. Complete inhibition was achieved with 60 microM CMP-Neu5Ac, and highly positive cooperativity (Hill coefficient of 4.1) was found for inhibitor binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305887     DOI: 10.1074/jbc.272.39.24313

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  Sialylation is essential for early development in mice.

Authors:  Martina Schwarzkopf; Klaus-Peter Knobeloch; Elvira Rohde; Stephan Hinderlich; Nicola Wiechens; Lothar Lucka; Ivan Horak; Werner Reutter; Rüdiger Horstkorte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

2.  Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex.

Authors:  Gregory Nemunaitis; Chris M Jay; Phillip B Maples; William A Gahl; Marjan Huizing; Tal Yardeni; Alex W Tong; Anagha P Phadke; Beena O Pappen; Cynthia Bedell; Henry Allen; Cathy Hernandez; Nancy S Templeton; Joseph Kuhn; Neil Senzer; John Nemunaitis
Journal:  Hum Gene Ther       Date:  2011-04-25       Impact factor: 5.695

3.  Domain-specific characteristics of the bifunctional key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.

Authors:  Astrid Blume; Wenke Weidemann; Ulrich Stelzl; Erich E Wanker; Lothar Lucka; Peter Donner; Werner Reutter; Rüdiger Horstkorte; Stephan Hinderlich
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

4.  An empirical extremum principle for the hill coefficient in ligand-protein interactions showing negative cooperativity.

Authors:  Hagai Abeliovich
Journal:  Biophys J       Date:  2005-04-15       Impact factor: 4.033

5.  Sizing up sialic acid in glomerular disease.

Authors:  Susan E Quaggin
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

6.  Convergent pathways for utilization of the amino sugars N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid by Escherichia coli.

Authors:  J Plumbridge; E Vimr
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

7.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of N-acetylmannosamine kinase from methicillin-resistant Staphylococcus aureus.

Authors:  Rachel A North; Simona Seizova; Anja Stampfli; Sarah A Kessans; Hironori Suzuki; Michael D W Griffin; Marc Kvansakul; Renwick C J Dobson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-17       Impact factor: 1.056

8.  Biochemical characterization of human and murine isoforms of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE).

Authors:  Stefan O Reinke; Colin Eidenschink; Chris M Jay; Stephan Hinderlich
Journal:  Glycoconj J       Date:  2008-09-23       Impact factor: 2.916

9.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08

10.  Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2).

Authors:  Chris Jay; Gregory Nemunaitis; John Nemunaitis; Neil Senzer; Stephan Hinderlich; Daniel Darvish; Julie Ogden; John Eager; Alex Tong; Phillip B Maples
Journal:  Gene Regul Syst Bio       Date:  2008-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.